- Tytuł:
- Cost-effectiveness of the addition of CDK4/6 inhibitors to standard endocrine therapy in first-line treatment of women with advanced HR+/HER2− breast cancer in Mexico
- Autorzy:
- Źródło:
- Clinical and Translational Oncology. 26(1):239-244
Czasopismo naukowe